Cowealth Medical Holding Co., Ltd. (TPEX:4745)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
10.40
-0.40 (-3.70%)
Jul 30, 2026, 1:30 PM CST

Cowealth Medical Holding Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-247.25-246.560.6349.1194.12139.46
Depreciation & Amortization
40.4542.3544.3451.4855.0367.03
Other Amortization
8.067.726.613.552.262.83
Loss (Gain) From Sale of Assets
0.020.01-1.74-0.630.790.02
Loss (Gain) From Sale of Investments
-0.91-1.19-1.82-17.58-7.5-
Loss (Gain) on Equity Investments
1.191.33-0.64-0.5-0.110.07
Provision & Write-off of Bad Debts
-86.03-95.84-6.09-20.6520.2729.32
Other Operating Activities
-140-71.5492.17133.92192.4258.3
Change in Accounts Receivable
426.21294.18-82.67109.86-805.97-114.88
Change in Inventory
36.51-69.9938.83181.24-53.78-186.68
Change in Accounts Payable
70.2313.53-35.12-65.77233.96-56.76
Change in Unearned Revenue
-9.16-3.414.3-1.64-51.1-
Change in Other Net Operating Assets
-500.94144.94410.65-377.3752.03-57.08
Operating Cash Flow
-401.6215.53469.4345.02-267.59-118.38
Operating Cash Flow Growth
--96.69%942.66%---

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-7.41-9.07-57.45-206.37-18.68-34.54
Sale of Property, Plant & Equipment
0.010.633.220.771.390.13
Divestitures
431.94431.94----
Sale (Purchase) of Intangibles
-5.63-5.63-4.9-30.13-7.69-2.12
Investment in Securities
-196.62-554.3-22.28113.23-253.947.21
Other Investing Activities
-43.75-37.6126.56-50.787.9215.81
Investing Cash Flow
178.55-174.03-54.86-173.28-271-13.51

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-0.08-8.26-27.24
Long-Term Debt Issued
-20----
Total Debt Issued
230.4320.08-8.26-27.24
Short-Term Debt Repaid
---82.25--191.13-
Long-Term Debt Repaid
--19.7-48.34-56.11-61.03-111.01
Total Debt Repaid
7.56-19.7-130.59-56.11-252.15-111.01
Net Debt Issued (Repaid)
237.990.38-130.59-47.85-252.15-83.78
Repurchase of Common Stock
-12.18-----
Common Dividends Paid
---30.98-123.92-116.17-92.94
Other Financing Activities
-108.15-122.61-77.35-144.721,434-21.84
Financing Cash Flow
117.67-122.23-238.92-316.481,066-198.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.2541.4172.45-103.9313.22-38.04
Net Cash Flow
-112.65-239.34348.11-548.66540.71-368.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-409.036.46411.98-161.34-286.27-152.91
Free Cash Flow Growth
--98.43%----
Free Cash Flow Margin
-14.28%0.22%9.83%-3.35%-5.09%-2.97%
Free Cash Flow Per Share
-5.280.085.32-2.08-3.69-1.97
Levered Free Cash Flow
28.8409.69341.51-132.81-455.38-179.74
Unlevered Free Cash Flow
42.66423.89359.59-111.1-439.78-164.5

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
9.3822.7729.4934.624.5621.84
Cash Income Tax Paid
154.7283.6656.25135.4131.71166.45
Change in Working Capital
22.85379.25335.98-153.67-624.87-415.4